| Taurine Metabolism and Taurine Transporter | |
| Metabolism of Taurine in Microorganisms: A Primer in Molecular Biodiversity? | p. 3 |
| The Reactivity of Hypotaurine and Cysteine Sulfinic Acid with Peroxynitrite | p. 15 |
| Cysteamine Dioxygenase: Evidence for the Physiological Conversion of Cysteamine to Hypotaurine in Rat and Mouse Tissues | p. 25 |
| In Vivo Regulation of Cysteine Dioxygenase via the Ubiquitin-26S Proteosome System | p. 37 |
| Osmosensitive Gene Expression of Taurine Transporter and Cyclin C in Embryonic Fibroblast Cells | p. 49 |
| Is TauT an Anti-Apoptotic Gene? | p. 59 |
| Gene Expressions of Taurine Transporter and Taurine Biosynthetic Enzyme during Mouse and Chicken Embryonic Development | p. 69 |
| Mechanisms of Regulation of Taurine Transporter Activity: A Complex Interplay of Regulatory Systems | p. 79 |
| TauT Gene Expression Is Regulated by TonEBP and Plays a Role in Cell Survival | p. 91 |
| Multiple PLA[subscript 2] Isoforms Regulate Taurine Release in NIH3T3 Mouse Fibroblasts | p. 99 |
| Properties of Volume-Activated Taurine Efflux from Human Breast Cancer Cells | p. 109 |
| Metabolic Effects of Taurine | |
| Taurine-Induced Changes in Transcription Profiling of Metabolism-Related Genes in Human Hepatoma Cells HepG2 | p. 119 |
| The Important Role of Taurine in Oxidative Metabolism | p. 129 |
| Characterization of Taurine as Inhibitor of Sodium Glucose Transporter | p. 137 |
| Taurine Attenuates Pyridoxal-Induced Adrenomedullry Catacholamine Release and Glycogenolysis in the Rat | p. 147 |
| Cytotoxicity of Taurine Metabolites Depends on the Cell Type | p. 157 |
| Effects of Dietary Salt and Fat on Taurine Excretion in Healthy and Diseased Rats | p. 173 |
| Clinical Significance of Plasma Taurine | |
| Plasma Taurine Reflects Sympathetic Tone | p. 181 |
| Spontaneously High Plasma Taurine Concentration Presages Bad Outcome If Challenged with Ischemia | p. 188 |
| Effects of Taurine on mRNA Levels of Nuclear Receptors and Factors Involved in Cholesterol and Bile Acid Homeostasis in Mice | p. 193 |
| Comparison of the Effects of Taurine with Those of Related Sulfur-Containing Compounds on Pyridoxal-Induced Adrenomedullary Cateholamine Release and Glycogenolysis in the Rat | p. 203 |
| Accumulation of Taurine in Tumor and Inflammatory Lesions | p. 213 |
| Effects of Taurine Supplementation | |
| Effects of Garlic Powder and Taurine Supplementation on Abdominal Fat, Muscle Weight, and Blood Amino Acid Pattern in Ovariectomized Rats | p. 221 |
| Effects of Garlic Powder and Soy Protein Supplementation on Blood Lipid Profiles and Amino Acid Concentrations in Postmenopausal Hyperlipidemic Model Rats | p. 227 |
| The Effect of Dietary Taurine Supplementation on Plasma and Liver Lipid Concentrations and Free Amino Acid Concentrations in Rats Fed a High-Cholesterol Diet | p. 235 |
| The Effect of Dietary Taurine Supplementation on Plasma and Liver Lipid Concentrations and Mineral Metabolism in Rats Fed Alcohol | p. 243 |
| Effects of Taurine Supplementation on Cholesterol Levels with Potential Ramification in Atherosclerosis | p. 251 |
| Taurine in Heart and Muscles | |
| Molecular Mechanisms of Cardioprotection by Taurine on Ischemia-Induced Apoptosis in Cultured Cardiomyocytes | p. 257 |
| Myogenic Induction of Taurine Transporter Prevents Dexamethasone-Induced Muscle Atrophy | p. 265 |
| Regionally Perfused Taurine | |
| Minimizes Lactic Acidosis and Preserves CKMB and Myocardial Contractility after Ischemia/Reperfusion | p. 271 |
| Taurine Addition to St Thomas' Solution Prevents DNA Oxidative Stress and Maintains Contractile Function | p. 279 |
| Taurine in Brain and Retina | |
| The Effect of Oxidative Stress on the Transport of Taurine in an in Vitro Model of the Blood Brain Barrier | p. 291 |
| Neuroprotection by Taurine and Taurine Analogues | p. 299 |
| Taurine Transporter Regulation in Hippocampal Neurons | p. 307 |
| Taurine and Brain Excitability | p. 315 |
| Systematically Administered Taurine | |
| Central Nervous System Effects | p. 323 |
| Systematically Administered Taurine Protects in Hypothermia and Normothermia | p. 330 |
| Systemically Administered Taurine: Pharmacologically Activated Mechanisms | p. 335 |
| Effects of Taurine on Cerebral Blood Flow Perfusion, Cell Apoptosis, and Infarct Volume in Acute Cerebral Ischemic Rats | p. 353 |
| The Mechanisms of Taurine's Protective Action against Acute Guanidino Neurotoxicity | p. 359 |
| Properties of Basal Taurine Release in the Rat Striatum in Vivo | p. 365 |
| Neuroprotective Mechanisms of Taurine in Vivo | p. 377 |
| Taurine Participates in the Anticonvulsive Effect of Electroacupuncture | p. 389 |
| Involvement of Taurine in Cerebral Ischemia and Electroacupuncture Anti-Ischemia | p. 395 |
| Mechanisms of Long-Lasting Enhancement of Corticostriatal Neurotransmission by Taurine | p. 401 |
| Increased GAD-Positive Neurons in the Cortex of Taurine-Fed Mice | p. 411 |
| Taurine Concentration in Human Gliomas and Meningiomas: Tumoral, Peritumoral, and Extratumoral Tissue | p. 419 |
| Taurine Transport and Transporter Localization in Peripheral Blood Lymphocytes of Controls and Major Depression Patients | p. 423 |
| Retina and Optic Tectum Interact to Modulate Taurine Effect on Goldfish and Rat Retinal Explants Outgrowth | p. 427 |
| Neuritic Outgrowth from Goldfish Retinal Explants, Interaction of Taurine and Zinc | p. 435 |
| Taurine Derivatives | |
| Taurine, Taurine Analogues, and Taurine Functions: Overview | p. 443 |
| Taurine Analogues and Taurine Transport: Therapeutic Advanges | p. 449 |
| Taurine, Taurine Analogues, and Mitochondrial Function and Dysfunction | p. 469 |
| Anti-Inflammatory Effects of Taurine Derivatives (Taurine Chloramine, Taurine Bromamine, and Taurolidine) Are Mediated by Different Mechanisms | p. 481 |
| Taurine Chloramine Inhibits the Production of Nitric Oxide and Superoxide Anion by Modulating Specific Mitogen-Activated Protein Kinases | p. 493 |
| Anti-Neurotoxic Effects of Tauropyrone, a Taurine Analogue | p. 499 |
| Taurinamide Derivatives - Drugs with the Metabolic Type of Action | |
| Minireview | p. 509 |
| Potential Antiatherosclerotic Drugs: Novel N-Substituted Taurinamide Derivatives | p. 515 |
| Antihypoxic Properties of Taurinamide Derivatives: The Experimental Study | p. 523 |
| The Influence of a Taurinamide Derivative on Skin Wound Healing in Rats: The Experimental Study | p. 529 |
| Cardioprotective Effect of Taurhythman: The Experimental Study | p. 535 |
| Neuroprotective Effect of a New Taurinamide Derivative - Taurepar | p. 543 |
| Index | p. 551 |
| Table of Contents provided by Ingram. All Rights Reserved. |
